Item 5.07 Submission of Matters to a Vote of Security Holders.

The 2023 annual meeting of stockholders for Aytu BioPharma, Inc. was held on May 18, 2023 (the "2023 Annual Meeting"). Of the 3,778,722 shares outstanding on the record date for the meeting, a total of 1,942,164 shares were present or represented at the meeting. The matters voted on and the results of the votes at the 2023 Annual Meeting are as follows:

1. Our stockholders elected five members to our board of directors as follows:




                       Number of Votes       Number of Votes       Number of Broker
                           Cast For              Withheld             Non-Votes
Members
Joshua R. Disbrow               673,707               315,837               952,620
John A. Donofrio, Jr.           677,912               311,632               952,620
Carl C. Dockery                 678,532               311,012               952,620
Vivian H. Liu                   685,411               304,133               952,620

The approval of a new equity incentive plan for certain officers, directors,

2. employees and other key personnel, the "2023 Equity Incentive Plan" was


    approved with 632,357 votes in favor, 352,359 votes against, and 4,828
    abstentions. There were 952,620 broker non-votes.


    The ratification of the appointment of Grant Thornton, LLC as the Company's

3. independent registered public accounting firm for the fiscal year ending June


    30, 2023 was approved with 1,754,922 votes in favor, 132,135 votes against and
    55,107 abstentions.


    The advisory vote on executive compensation was approved with 587,253 votes in

4. favor, 383,698 votes against and 18,593 abstentions. There were 952,620 broker

non-votes.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Description

104 Cover Page Interactive Data File (the cover page XBRL tags are


           embedded within the inline XBRL document)

© Edgar Online, source Glimpses